Reuters logo
BRIEF- Seikagaku initiates phase II study of SI-613 for treatment of knee osteoarthritis in U.S.
June 16, 2017 / 4:16 AM / 3 months ago

BRIEF- Seikagaku initiates phase II study of SI-613 for treatment of knee osteoarthritis in U.S.

June 16(Reuters) - Seikagaku Corp

* Says it announces the start of phase II study of SI-613 in patients with osteoarthritis of the knee, in the U.S.

Source text in Japanese:goo.gl/F8pM1P

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below